文献速递主动脉疾病

不同近端阻断水平下开放腹主动脉瘤修复术在正常与受损肾功能患者的30天结局

Thirty-day outcomes of open abdominal aortic aneurysm repair by proximal clamp level in patients with normal and impaired renal function.
PubMed 文献 · J Vasc Surg · 2020-09-03

本研究基于ACS NSQIP-targeted AAA数据库2012-2018年数据,纳入1808例择期开放腹主动脉瘤修复术患者,按肾功能分为正常组(eGFR≥60,n=1284)和慢性肾功能不全组(eGFR<60且未透析,n=524),比较不同近端阻断水平(肾下、肾间、肾上、腹腔干上)的30天结局。结果显示肾功能正常组仅腹腔干上阻断与肾下阻断相比急性肾衰竭增加,而慢性肾功能不全组腹腔干上阻断与肾下阻断相比肾复合并发症、缺血性结肠炎和30天死亡率均增加。

要点

  • 慢性肾功能不全患者腹腔干上阻断较肾下阻断30天死亡率显著增高(13.6% vs 2.4%)。
  • 肾功能正常患者仅腹腔干上阻断与肾下阻断相比急性肾衰竭增加(5.9% vs 1.5%)。
  • 应尽可能降低近端阻断水平,尤其对慢性肾功能不全患者。

核心结论

  • 在慢性肾功能不全患者择期开放腹主动脉瘤修复术中,腹腔干上阻断与死亡率增高相关,肾上阻断与肾脏并发症增加相关,而肾功能正常患者中这些效应不存在。

研究设计与样本

  • 回顾性队列研究,使用美国外科医师学会国家手术质量改进计划(ACS NSQIP)靶向AAA数据库2012至2018年数据。
  • 共纳入1808例择期开放腹主动脉瘤修复术患者,其中正常肾功能1284例,慢性肾功能不全524例。
  • 按近端阻断水平分为肾下(1080例,59.7%)、肾间(337例,18.6%)、肾上(279例,15.4%)和腹腔干上(112例,6.2%)四组。

主要发现

  • 正常肾功能组:腹腔干上阻断与肾下阻断相比急性肾衰竭增加(5.9% vs 1.5%;aOR 3.97;95%CI 1.04-5.18;P=.044),30天死亡率无差异。
  • 慢性肾功能不全组:腹腔干上阻断与肾下阻断相比肾复合并发症增加(22.7% vs 5.6%;aOR 8.81;95%CI 3.17-24.46;P<.001)和缺血性结肠炎增加(13.6% vs 3.0%;aOR 4.78;95%CI 1.38-16.62;P=.014)。
  • 慢性肾功能不全组:腹腔干上阻断与肾上阻断相比30天死亡率增加(13.6% vs 2.4%;aOR 6.00;95%CI 1.14-31.55;P=.034)和肾复合并发症增加(22.7% vs 10.8%;aOR 2.87;95%CI 1.02-8.13;P=.047)。
  • 慢性肾功能不全组:肾上阻断与肾下阻断相比肾功能障碍增加(10.8% vs 5.6%;aOR 2.77;95%CI 1.08-7.13;P=.035),死亡率无差异。
  • 两队列中肾间阻断与肾下阻断相比30天死亡率和并发症均无差异,主要不良心血管事件在各阻断水平间均无差异。

临床怎么用

  • 在慢性肾功能不全患者行开放腹主动脉瘤修复术时,应尽可能将近端阻断水平保持在肾下或肾间,以降低死亡率和肾脏并发症风险。
  • 对于肾功能正常患者,腹腔干上阻断时需警惕急性肾衰竭风险,但死亡率未见增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Open surgical repair (OSR) of abdominal aortic aneurysms (AAAs) has often been reserved in contemporary practice for complex aneurysms requiring a suprarenal or supraceliac proximal clamp level. The present study investigated the associated 30-day outcomes of different proximal clamp levels in OSR of complex infrarenal/juxtarenal AAA in patients with normal renal function and those with chronic renal insufficiency (CRI). METHODS: All patients undergoing elective OSR of infrarenal and juxtarenal AAA were identified in the American College of Surgeons National Surgical Quality Improvement Program-targeted AAA database from 2012 to 2018. The patients were stratified into two cohorts (normal renal function [estimated glomerular filtration rate, ≥60 mL/min] and CRI [estimated glomerular filtration rate, <60 mL/min and no dialysis]) before further substratification into groups by the proximal clamp level (infrarenal, inter-renal, suprarenal, and supraceliac). The 30-day outcomes, including mortality, renal and pulmonary complications, and major adverse cardiovascular event rates, were compared within each renal function cohort between proximal clamp level groups using the infrarenal clamp group as the reference. Supraceliac clamping was also compared with suprarenal clamping. RESULTS: A total of 1284 patients with normal renal function and 524 with CRI were included in the present study. The proximal clamp levels for the 1808 patients were infrarenal for 1080 (59.7%), inter-renal for 337 (18.6%), suprarenal for 279 (15.4%), and supraceliac for 112 (6.2%). In the normal renal function cohort, no difference was found in 30-day mortality with any clamp level. Increased 30-day acute renal failure was only observed in the supraceliac vs infrarenal clamp level comparison (5.9% vs 1.5%; adjusted odds ratio [aOR], 3.97; 95% confidence interval [CI], 1.04-5.18; P = .044). In the CRI cohort, supraceliac clamping was associated with an increased rate of renal composite complications (22.7% vs 5.6%; aOR, 8.81; 95% CI, 3.17-24.46; P < .001) and ischemic colitis (13.6% vs 3.0%; aOR, 4.78; 95% CI, 1.38-16.62; P = .014) compared with infrarenal clamping and greater 30-day mortality (13.6% vs 2.4%; aOR, 6.00; 95% CI, 1.14-31.55; P = .034) and renal composite complications (22.7% vs 10.8%; aOR, 2.87; 95% CI, 1.02-8.13; P = .047) compared with suprarenal clamping. Suprarenal clamping was associated with greater renal dysfunction (10.8% vs 5.6%; aOR, 2.77; 95% CI, 1.08-7.13; P = .035) compared with infrarenal clamping, with no differences in mortality. No differences were found in 30-day mortality or morbidity for inter-renal clamping compared with infrarenal clamping in either cohort. No differences were found in major adverse cardiovascular events with higher clamp levels in either cohort. CONCLUSIONS: In elective OSR of infrarenal and juxtarenal AAAs for patients with CRI, this study found a heightened mortality risk with supraceliac clamping and increased renal morbidity with suprarenal clamping, though these effects were not present for patients with normal renal function. Every effort should be made to keep the proximal clamp level as low as possible, especially in patients with CRI.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Rosenfeld ES, Macsata RA, Nguyen BN, et al. Thirty-day outcomes of open abdominal aortic aneurysm repair by proximal clamp level in patients with normal and impaired renal function. J Vasc Surg. 2020. PMID: 32890718. doi:10.1016/j.jvs.2020.08.122

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。